Managing Pain and Discomfort in Children with Cancer Clinton FullerHenry HuangRachel Thienprayoon Anesthesiology and Critical Care (JP Cata, Section Editor) 30 March 2022 Pages: 961 - 973
Neuro-oncologic Emergencies Paola Suarez-MeadeLina Marenco-HillembrandWendy J. Sherman Neuro-oncology (KS Nevel, Section Editor) 30 March 2022 Pages: 975 - 984
Ependymoma: Evaluation and Management Updates Roberta RudàFrancesco BrunoRiccardo Soffietti Neuro-oncology (KS Nevel, Section Editor) Open access 06 April 2022 Pages: 985 - 993
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia Punita GroverLori Muffly Leukemia (A Aguayo, Section Editor) 30 March 2022 Pages: 995 - 1001
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies Daniel RiveraAlessandra Ferrajoli Leukemia (A Aguayo, Section Editor) 02 April 2022 Pages: 1003 - 1014
Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment? Marie C. BénéAnna Porwit Leukemia (A Aguayo, Section Editor) Open access 05 April 2022 Pages: 1015 - 1022
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions Cho Rong BaeMa. Nessa GelvosaJae Yong Jeon Cancer Rehabilitation (S Shahpar, Section Editor) 01 April 2022 Pages: 1023 - 1033
Role of Image-Guided Percutaneous Needle Biopsy in the Age of Precision Medicine Miyuki SoneShunsuke SugawaraYasushi Yatabe Interventional Oncology (DC Madoff, Section Editor) 01 April 2022 Pages: 1035 - 1044
Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy Sae Rom ChungJung Hwan BaekJeong Hyun Lee Interventional Oncology (DC Madoff, Section Editor) 06 April 2022 Pages: 1045 - 1052
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies Kristina Ihrmark LundbergDiana TreisJohn Inge Johnsen Pediatric Oncology (KL Davis, Section Editor) Open access 01 April 2022 Pages: 1053 - 1062
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction Irma ZhangAna Barac Cardio-oncology (JN Upshaw, Section Editor) 01 April 2022 Pages: 1063 - 1070
Triplet Therapy in Melanoma — Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies Julia R. Dixon-DouglasRiyaben P. PatelGrant A. McArthur Melanoma (DB Johnson, Section Editor) Open access 02 April 2022 Pages: 1071 - 1079
Richter’s Transformation Audrey M. SigmundAdam S. Kittai Lymphomas (T Hilal, Section Editor) 06 April 2022 Pages: 1081 - 1090